Áron Szigetvári
Budapest University of Technology and Economics
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Áron Szigetvári.
Journal of Flow Chemistry | 2015
Klára Lövei; István Greiner; János Éles; Áron Szigetvári; Miklós Dékány; Sándor Lévai; Zoltán Novák; György István Túrós
AbstractIn medicinal chemistry, the development of synthetic procedures for the access of new heterocyclic systems as potential scaffolds is elementary. Herein, we report our results on the formation of small drug-like heterocycles, utilizing flow chemistry. This approach enables the extension of the reaction parameter window, including high-pressure/high-temperature or hazardous chemistry. In our work, various novel condensed tricyclic benzothiazoles fused with furo- and thieno-rings were synthesized applying a multistep continuous-flow protocol. The process includes two ring closure steps and a nitro group reduction step. Batch and telescoped continuous-flow syntheses were also designed and performed.
Beilstein Journal of Organic Chemistry | 2016
Viktor Ilkei; András Spaits; Anita Prechl; Áron Szigetvári; Zoltán Béni; Miklós Dékány; Csaba Szántay; Judit Müller; Árpád Könczöl; Ádám Szappanos; Attila Mándi; Sándor Antus; Ana Martins; Attila Hunyadi; György T. Balogh; Gyorgy Kalaus; Hedvig Bölcskei; László Hazai; Tibor Kurtán
Starting from racemic naringenin ((±)-1), a mixture of dracocephin A stereoisomers 6-(2”-pyrrolidinone-5”-yl)naringenin (±)-2a–d and its regioisomer, dracocephin B 8-(2”-pyrrolidinone-5”-yl)naringenin (±)-3a–d originally isolated from Dracocephalum rupestre, have been synthesized in a one-pot reaction. The separation of 2a–d and 3a–d was achieved by preparative HPLC. The four stereoisomers of each natural product were separated by analytical chiral HPLC and their absolute configuration was studied by the combination of HPLC–ECD measurements and TDDFT–ECD calculations. The synthesized flavonoid alkaloids were further characterized by physicochemical and in vitro pharmacological studies.
Molecules | 2018
András Keglevich; Szabolcs Mayer; Réka Pápai; Áron Szigetvári; Zsuzsanna Sánta; Miklós Dékány; Csaba Szántay; Péter Keglevich; László Hazai
Our successful work for the synthesis of cyclopropanated vinblastine and its derivatives by the Simmons–Smith reaction was followed to build up further three-membered rings into the 14,15-position of the vindoline part of the dimer alkaloid. Halogenated 14,15-cyclopropanovindoline was prepared by reactions with iodoform and bromoform, respectively, in the presence of diethylzinc. Reactions of dichlorocarbene with vindoline resulted in the 10-formyl derivative. Unexpectedly, in the case of the dimer alkaloids vinblastine and vincristine, the rearranged products containing an oxirane ring in the catharanthine part were isolated from the reactions. The attempted epoxidation of vindoline and catharanthine also led to anomalous rearranged products. In the epoxidation reaction of vindoline, an o-quinonoid derivative was obtained, in the course of the epoxidation of catharanthine, a hydroxyindolenine type product and a spiro derivative formed by ring contraction reaction, were isolated. The coupling reaction of vindoline and the spiro derivative obtained in the epoxidation of catharanthine did not result in a bisindole alkaloid. Instead, two surprising vindoline trimers were discovered and characterized by NMR spectroscopy and mass spectrometry.
Journal of Peptide Science | 2018
Zoltán Bánóczi; András Keglevich; Ildikò Szabò; Ivan Ranđelović; Zita Hegedüs; Fruzsina L. Regenbach; Péter Keglevich; Zsófia Lengyel; Álmos Gorka-Kereskényi; Zsófia Dubrovay; Viktor Háda; Áron Szigetvári; Csaba Szántay; László Hazai; József Tóvári; Ferenc Hudecz
Some Vinca alkaloids (eg, vinblastine, vincristine) have been widely used as antitumor drugs for a long time. Unfortunately, vindoline, a main alkaloid component of Catharanthus roseus (L.) G. Don, itself, has no antitumor activity. In our novel research program, we have prepared and identified new vindoline derivatives with moderate cytostatic activity.
Tetrahedron | 2017
Viktor Ilkei; András Spaits; Anita Prechl; Judit Müller; Árpád Könczöl; Sándor Lévai; Eszter Riethmüller; Áron Szigetvári; Zoltán Béni; Miklós Dékány; Ana Martins; Attila Hunyadi; Sándor Antus; Csaba Szántay; György T. Balogh; Gyorgy Kalaus; Hedvig Bölcskei; László Hazai
Organic Process Research & Development | 2017
Péter Bana; Ágnes Lakó; Nóra Zsuzsa Kiss; Zoltán Béni; Áron Szigetvári; János Kóti; György István Túrós; János Éles; István Greiner
Periodica Polytechnica Chemical Engineering | 2017
Szabolcs Mayer; Péter Keglevich; Péter Ábrányi-Balogh; Áron Szigetvári; Miklós Dékány; Csaba Szántay; László Hazai
Heteroatom Chemistry | 2017
György Keglevich; Zita Rádai; Nikoletta Harsági; Áron Szigetvári; Nóra Zsuzsa Kiss
European Journal of Medicinal Chemistry | 2017
János Galambos; Attila Bielik; Gábor Wágner; György Domány; János Kóti; Zoltán Béni; Áron Szigetvári; Zsuzsanna Sánta; Zoltán Orgován; Amrita Bobok; Béla Kiss; Mónika L. Mikó-Bakk; Mónika Vastag; Katalin Saghy; Mikhail Krasavin; Krisztina Gál; István Greiner; Zsolt Szombathelyi; György M. Keserű
Tetrahedron Letters | 2016
Péter Keglevich; Péter Ábrányi-Balogh; Áron Szigetvári; Csaba Szántay; László Hazai